Cancer immunotherapy with autologous and allogeneic vaccines: a practical overview.
Shinitzky
M
M
Department of Membrane Research, Weizmann Institute of Science, Rehovot, Israel.
Skornick
Y
Y
D000818:Animals; D000951:Antigens, Neoplasm / Q000008:administration & dosage / Q000276:immunology* / Q000302:isolation & purification; D002462:Cell Membrane / Q000187:drug effects; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D008213:Lymphocyte Activation; D008285:Major Histocompatibility Complex; D009363:Neoplasm Proteins / Q000276:immunology; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000276:immunology / Q000628:therapy; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000276:immunology; D014612:Vaccines / Q000145:classification / Q000276:immunology* / Q000302:isolation & purification
D000951:Antigens, Neoplasm; D009363:Neoplasm Proteins; D014612:Vaccines